查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1193142

電子喉（Electrolarynx）市場：按類型（內部電池,外部電池）,應用（喉癌,言語康復）,最終用戶（醫院,門診手術中心等）分類：2021-2031 年全球機會分析和行業預測

Electrolarynx Market By Type (Built-in Battery, External Battery), By Application (Laryngeal Cancer, Speech Rehabilitation), By End user (Hospitals, Ambulatory Surgical Centers, others): Global Opportunity Analysis and Industry Forecast, 2021-2031
出版日期: | 出版商: Allied Market Research | 英文 190 Pages | 商品交期: 2-3個工作天內

價格

全球電子喉頭市場預計到 2021 年將達到 4.095 億美元，到 2031 年將達到 7.03 億美元，從 2022 年到 2031 年的複合年增長率為 5.5%。

Electrolarynx 是一種電池供電的設備，可以發出聲音以便人們說話。 它們有多種品牌和型號，但通常只有小型電動剃須刀那麼大。 當人們想說話時，將這個小型電池供電的小工具戴在脖子下巴下方。 當您按下按鈕時，振動會通過您的皮膚傳遞到您的喉嚨。 用你的嘴巴,舌頭,嘴唇和牙齒表達那個聲音，然後把它變成文字。

人工喉是一種通過調整和存儲聲音的頻率參數，使失聲的人能夠更好地說話的裝置。 嗓音恢復器在喉切除術後最有用，在喉切除術中，整個聲帶（稱為喉）被永久切除，將氣管與食道分開。

推動市場增長的關鍵因素是喉癌患病率上升以及酒精和煙草消費激增，這是推動電子喉市場的主要因素。 例如，根據美國癌症協會發布的一份報告，估計2022年美國約有12,470例新發喉癌死亡病例（男性9,820例，女性2,650例）（男性3,070例，女性750例）。 此外，由人乳頭瘤病毒 (HPV) 引起的呼吸道乳頭狀瘤病例越來越多，這表明它通常是良性的（不會癌變）。 這些腫瘤會導致聲帶損傷和氣道問題，從而增加對電子喉部設備的需求並推動市場增長。 此外，這些醫療設備的高采用率以及許多主要參與者為推出創新和技術先進的電子喉設備而在研發方面的持續投資預計將推動市場的增長。

然而，電子喉裝置的高成本阻礙了市場的增長。 相反，下嚥癌病例的增加,新興國家醫療保健市場的興起,無法獲得基本醫療保健的低收入國家以及喉癌風險的增加預計將在預測期內對市場產生影響。預計提供有利可圖的增長機會。

內容

第一章介紹

第 2 章執行摘要

第 3 章市場概述

  • 市場定義和範圍
  • 主要發現
    • 主要投資領域
  • 波特的五力分析
  • 主要公司的定位
  • 市場動態
    • 司機
    • 約束因素
    • 機會
  • COVID-19 影響分析

第 4 章 Electrolarynx 市場：按類型分類

  • 概覽
    • 市場規模和預測
  • 內置電池
    • 主要市場趨勢,增長因素和機遇
    • 市場規模和預測：按地區
    • 市場份額分析：按國家/地區分類
  • 外接電池
    • 主要市場趨勢,增長因素和機遇
    • 市場規模和預測：按地區
    • 市場份額分析：按國家/地區分類

第 5 章 Electrolarynx 市場：按應用分類

  • 概覽
    • 市場規模和預測
  • 喉癌
    • 主要市場趨勢,增長因素和機遇
    • 市場規模和預測：按地區
    • 市場份額分析：按國家/地區分類
  • 言語康復
    • 主要市場趨勢,增長因素和機遇
    • 市場規模和預測：按地區
    • 市場份額分析：按國家/地區分類

第 6 章 Electrolarynx 市場：按最終用戶分類

  • 概覽
    • 市場規模和預測
  • 醫院
    • 主要市場趨勢,增長動力和機遇
    • 市場規模和預測：按地區
    • 市場份額分析：按國家/地區分類
  • 門診手術中心
    • 主要市場趨勢,增長因素和機遇
    • 市場規模和預測：按地區
    • 市場份額分析：按國家/地區分類
  • 其他
    • 主要市場趨勢,增長因素和機遇
    • 市場規模和預測：按地區
    • 市場份額分析：按國家/地區分類

第 7 章 Electrolarynx 市場：按地區

  • 概覽
    • 市場規模和預測
  • 北美
    • 主要趨勢和機遇
    • 北美市場規模和預測：按類型
    • 北美市場規模和預測：按應用
    • 北美市場規模和預測：按最終用戶分類
    • 北美市場規模和預測：按國家/地區分類
      • 美國
      • 加拿大
      • 墨西哥
  • 歐洲
    • 主要趨勢和機遇
    • 歐洲市場規模和預測：按類型
    • 歐洲市場規模和預測：按應用分類
    • 歐洲市場規模和預測：按最終用戶分類
    • 歐洲市場規模和預測：按國家/地區分類
      • 德國
      • 法國
      • 英國
      • 意大利
      • 西班牙
      • 其他歐洲地區
  • 亞太地區
    • 主要趨勢和機遇
    • 亞太市場規模和預測：按類型
    • 亞太市場規模和預測：按應用
    • 亞太市場規模和預測：按最終用戶分類
    • 亞太地區的市場規模和預測：按國家/地區分類
      • 日本
      • 中國
      • 澳大利亞
      • 印度
      • 韓國
      • 其他亞太地區
  • 拉美
    • 主要趨勢和機遇
    • LAMEA 市場規模和預測：按類型
    • LAMEA 市場規模和預測：按應用分類
    • LAMEA 市場規模和預測：按最終用戶分類
    • LAMEA 市場規模和預測：按國家/地區分類
      • 巴西
      • 沙特阿拉伯
      • 南非
      • 其他拉美地區

第八章公司情況

  • 介紹
  • 關鍵成功策略
  • 10 家主要公司的產品映射
  • 比賽儀表板
  • 競爭熱圖
  • 主要發展

第九章公司簡介

  • Ultravoice Limited
  • Inhealth Technologies
  • Griffin Labs
  • Servona GmbH
  • Labex Trade
  • AMPLICORD DI GABRIELLA SALVATORE
  • Romet Limted
  • Nu-Vois, LLC
  • Andreas Fahl Medizintechnik-Vertrieb GmbH
  • Atos Medical AB
Product Code: A15637

The global electrolarynx market was valued at $409.5 million in 2021 and is projected to reach $703.0 million by 2031, registering a CAGR of 5.5% from 2022 to 2031. An electronic larynx (electrolarynx) is battery-powered equipment that generates sound so that a person can speak. There are various makes and models, but they are typically the size of a small electric razor. When a person wants to talk, this little, battery-operated gadget is put right on the neck, beneath the chin. The electrolarynx produces a vibration that is sent via the skin to the throat when a person presses a button on the device. With the mouth, tongue, lips, and teeth, the patient forms this sound into words.

The artificial larynx device allows individuals who have lost their voice to adjust and save several sound frequency parameters to produce improved speech. Voice restoration devices are most utilized after a laryngectomy, in which the whole voice box, known as the larynx, is permanently removed, separating the windpipe and food pipe.

The key factors that drive the growth of the market are the rise in the prevalence of laryngeal cancer and the surge in the consumption of alcohol and tobacco are the major factors drive the electrolarynx market. For instance, according to the report published by the American Cancer Society, it has been estimated for laryngeal cancer in the U.S. for 2022 that, about 12,470 new cases of laryngeal cancer (9,820 in men and 2,650 in women) were recorded in about 3,820 people (3,070 men and 750 women) died from laryngeal cancer. Furthermore, the increase in the cases of respiratory papilloma which is caused by the human papillomavirus (HPV) is usually benign (non-cancerous). These growths can lead to vocal cord damage and airway problems, which increases the demand for electrolarynx devices hence propelling the growth of the market. Moreover, the high adoption of these medical devices and continuously investing in R&D by numerous key players for the launch of innovative and technologically advanced electrolarynx devices are anticipated to fuel the market growth.

However, the high cost of electrolarynx devices hampers market growth. Conversely, rising cases of hypopharyngeal cancer, the emerging healthcare market in developing countries, and low-income countries lacking access to basic healthcare, and an increase in the risk of laryngeal cancer are expected to provide a lucrative opportunity for the growth of the market during the forecast period. 

The electrolarynx market is segmented on the basis of type, application, end-user, and region. By type, the market is segmented into external batteries and built-in batteries. By application, it is bifurcated into laryngeal cancer and speech rehabilitation. By end user, the market is segmented into hospitals, ambulatory surgical centers, and others. Region-wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

North America accounted for a majority of the electrolarynx market share in 2021 and is anticipated to remain dominant during the forecast period. The electrolarynx market is mainly driven by the presence of well-established healthcare facilities and a high prevalence rate of laryngeal cancer. Moreover, an increase in the number of people consuming alcohol and tobacco and a rise in the demand for electrolarynx devices are contributing to the market growth in the region. Furthermore, an increasing number of key players in this region are involved in R&D activities for the development of technologically advanced medical devices, and the initiatives being undertaken by various organizations to spread awareness and reduce the prevalence rate of hypopharyngeal cancer through innovative research are expected to fuel the market growth.

Asia-Pacific is expected to register the fastest CAGR during the forecast period. This is due to the presence of high unmet medical needs and constantly improving healthcare infrastructure. In addition, the rapidly growing population, various lifestyle changes such as the high rate of people consuming alcohol and tobacco, rising incidence of laryngeal cancer, improvement in the quality of diagnosis, and increasing patient affordability are set to drive the market in the Asia-Pacific region. This helps several market players to invest in Asia-Pacific countries, which in turn will further contribute to the growth of the market.

The key players that operate in the electrolarynx market are Atos Medical, Amplicord, Fountain Head Marketing, Inc., Medline Industries, Nu Vois, Labaex, InHealth Technologies, Romet, Servona GmbH, Luminaud, and Ultravoice.

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the electrolarynx market analysis from 2021 to 2031 to identify the prevailing electrolarynx market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders to make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the electrolarynx market segmentation assists in determining the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes an analysis of the regional as well as global electrolarynx market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Type

  • Built-in Battery
  • External Battery

By Application

  • Laryngeal Cancer
  • Speech Rehabilitation

By End user

  • Hospitals
  • Ambulatory Surgical Centers
  • others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • Australia
    • India
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA
  • Key Market Players
    • Ultravoice Limited
    • Inhealth Technologies
    • Griffin Labs
    • Servona GmbH
    • Labex Trade
    • AMPLICORD DI GABRIELLA SALVATORE
    • Romet Limted
    • Nu-Vois, LLC
    • Andreas Fahl Medizintechnik - Vertrieb GmbH
    • Atos Medical AB

TABLE OF CONTENTS

CHAPTER 1:INTRODUCTION

  • 1.1.Report description
  • 1.2.Key market segments
  • 1.3.Key benefits to the stakeholders
  • 1.4.Research Methodology
    • 1.4.1.Secondary research
    • 1.4.2.Primary research
    • 1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

  • 2.1.Key findings of the study
  • 2.2.CXO Perspective

CHAPTER 3:MARKET OVERVIEW

  • 3.1.Market definition and scope
  • 3.2.Key findings
    • 3.2.1.Top investment pockets
  • 3.3.Porter's five forces analysis
  • 3.4.Top player positioning
  • 3.5.Market dynamics
    • 3.5.1.Drivers
    • 3.5.2.Restraints
    • 3.5.3.Opportunities
  • 3.6.COVID-19 Impact Analysis on the market

CHAPTER 4: ELECTROLARYNX MARKET, BY TYPE

  • 4.1 Overview
    • 4.1.1 Market size and forecast
  • 4.2 Built-in Battery
    • 4.2.1 Key market trends, growth factors and opportunities
    • 4.2.2 Market size and forecast, by region
    • 4.2.3 Market share analysis by country
  • 4.3 External Battery
    • 4.3.1 Key market trends, growth factors and opportunities
    • 4.3.2 Market size and forecast, by region
    • 4.3.3 Market share analysis by country

CHAPTER 5: ELECTROLARYNX MARKET, BY APPLICATION

  • 5.1 Overview
    • 5.1.1 Market size and forecast
  • 5.2 Laryngeal Cancer
    • 5.2.1 Key market trends, growth factors and opportunities
    • 5.2.2 Market size and forecast, by region
    • 5.2.3 Market share analysis by country
  • 5.3 Speech Rehabilitation
    • 5.3.1 Key market trends, growth factors and opportunities
    • 5.3.2 Market size and forecast, by region
    • 5.3.3 Market share analysis by country

CHAPTER 6: ELECTROLARYNX MARKET, BY END USER

  • 6.1 Overview
    • 6.1.1 Market size and forecast
  • 6.2 Hospitals
    • 6.2.1 Key market trends, growth factors and opportunities
    • 6.2.2 Market size and forecast, by region
    • 6.2.3 Market share analysis by country
  • 6.3 Ambulatory Surgical Centers
    • 6.3.1 Key market trends, growth factors and opportunities
    • 6.3.2 Market size and forecast, by region
    • 6.3.3 Market share analysis by country
  • 6.4 others
    • 6.4.1 Key market trends, growth factors and opportunities
    • 6.4.2 Market size and forecast, by region
    • 6.4.3 Market share analysis by country

CHAPTER 7: ELECTROLARYNX MARKET, BY REGION

  • 7.1 Overview
    • 7.1.1 Market size and forecast
  • 7.2 North America
    • 7.2.1 Key trends and opportunities
    • 7.2.2 North America Market size and forecast, by Type
    • 7.2.3 North America Market size and forecast, by Application
    • 7.2.4 North America Market size and forecast, by End user
    • 7.2.5 North America Market size and forecast, by country
      • 7.2.5.1 U.S.
      • 7.2.5.1.1 Key market trends, growth factors and opportunities
      • 7.2.5.1.2 Market size and forecast, by Type
      • 7.2.5.1.3 Market size and forecast, by Application
      • 7.2.5.1.4 Market size and forecast, by End user
      • 7.2.5.2 Canada
      • 7.2.5.2.1 Key market trends, growth factors and opportunities
      • 7.2.5.2.2 Market size and forecast, by Type
      • 7.2.5.2.3 Market size and forecast, by Application
      • 7.2.5.2.4 Market size and forecast, by End user
      • 7.2.5.3 Mexico
      • 7.2.5.3.1 Key market trends, growth factors and opportunities
      • 7.2.5.3.2 Market size and forecast, by Type
      • 7.2.5.3.3 Market size and forecast, by Application
      • 7.2.5.3.4 Market size and forecast, by End user
  • 7.3 Europe
    • 7.3.1 Key trends and opportunities
    • 7.3.2 Europe Market size and forecast, by Type
    • 7.3.3 Europe Market size and forecast, by Application
    • 7.3.4 Europe Market size and forecast, by End user
    • 7.3.5 Europe Market size and forecast, by country
      • 7.3.5.1 Germany
      • 7.3.5.1.1 Key market trends, growth factors and opportunities
      • 7.3.5.1.2 Market size and forecast, by Type
      • 7.3.5.1.3 Market size and forecast, by Application
      • 7.3.5.1.4 Market size and forecast, by End user
      • 7.3.5.2 France
      • 7.3.5.2.1 Key market trends, growth factors and opportunities
      • 7.3.5.2.2 Market size and forecast, by Type
      • 7.3.5.2.3 Market size and forecast, by Application
      • 7.3.5.2.4 Market size and forecast, by End user
      • 7.3.5.3 UK
      • 7.3.5.3.1 Key market trends, growth factors and opportunities
      • 7.3.5.3.2 Market size and forecast, by Type
      • 7.3.5.3.3 Market size and forecast, by Application
      • 7.3.5.3.4 Market size and forecast, by End user
      • 7.3.5.4 Italy
      • 7.3.5.4.1 Key market trends, growth factors and opportunities
      • 7.3.5.4.2 Market size and forecast, by Type
      • 7.3.5.4.3 Market size and forecast, by Application
      • 7.3.5.4.4 Market size and forecast, by End user
      • 7.3.5.5 Spain
      • 7.3.5.5.1 Key market trends, growth factors and opportunities
      • 7.3.5.5.2 Market size and forecast, by Type
      • 7.3.5.5.3 Market size and forecast, by Application
      • 7.3.5.5.4 Market size and forecast, by End user
      • 7.3.5.6 Rest of Europe
      • 7.3.5.6.1 Key market trends, growth factors and opportunities
      • 7.3.5.6.2 Market size and forecast, by Type
      • 7.3.5.6.3 Market size and forecast, by Application
      • 7.3.5.6.4 Market size and forecast, by End user
  • 7.4 Asia-Pacific
    • 7.4.1 Key trends and opportunities
    • 7.4.2 Asia-Pacific Market size and forecast, by Type
    • 7.4.3 Asia-Pacific Market size and forecast, by Application
    • 7.4.4 Asia-Pacific Market size and forecast, by End user
    • 7.4.5 Asia-Pacific Market size and forecast, by country
      • 7.4.5.1 Japan
      • 7.4.5.1.1 Key market trends, growth factors and opportunities
      • 7.4.5.1.2 Market size and forecast, by Type
      • 7.4.5.1.3 Market size and forecast, by Application
      • 7.4.5.1.4 Market size and forecast, by End user
      • 7.4.5.2 China
      • 7.4.5.2.1 Key market trends, growth factors and opportunities
      • 7.4.5.2.2 Market size and forecast, by Type
      • 7.4.5.2.3 Market size and forecast, by Application
      • 7.4.5.2.4 Market size and forecast, by End user
      • 7.4.5.3 Australia
      • 7.4.5.3.1 Key market trends, growth factors and opportunities
      • 7.4.5.3.2 Market size and forecast, by Type
      • 7.4.5.3.3 Market size and forecast, by Application
      • 7.4.5.3.4 Market size and forecast, by End user
      • 7.4.5.4 India
      • 7.4.5.4.1 Key market trends, growth factors and opportunities
      • 7.4.5.4.2 Market size and forecast, by Type
      • 7.4.5.4.3 Market size and forecast, by Application
      • 7.4.5.4.4 Market size and forecast, by End user
      • 7.4.5.5 South Korea
      • 7.4.5.5.1 Key market trends, growth factors and opportunities
      • 7.4.5.5.2 Market size and forecast, by Type
      • 7.4.5.5.3 Market size and forecast, by Application
      • 7.4.5.5.4 Market size and forecast, by End user
      • 7.4.5.6 Rest of Asia-Pacific
      • 7.4.5.6.1 Key market trends, growth factors and opportunities
      • 7.4.5.6.2 Market size and forecast, by Type
      • 7.4.5.6.3 Market size and forecast, by Application
      • 7.4.5.6.4 Market size and forecast, by End user
  • 7.5 LAMEA
    • 7.5.1 Key trends and opportunities
    • 7.5.2 LAMEA Market size and forecast, by Type
    • 7.5.3 LAMEA Market size and forecast, by Application
    • 7.5.4 LAMEA Market size and forecast, by End user
    • 7.5.5 LAMEA Market size and forecast, by country
      • 7.5.5.1 Brazil
      • 7.5.5.1.1 Key market trends, growth factors and opportunities
      • 7.5.5.1.2 Market size and forecast, by Type
      • 7.5.5.1.3 Market size and forecast, by Application
      • 7.5.5.1.4 Market size and forecast, by End user
      • 7.5.5.2 Saudi Arabia
      • 7.5.5.2.1 Key market trends, growth factors and opportunities
      • 7.5.5.2.2 Market size and forecast, by Type
      • 7.5.5.2.3 Market size and forecast, by Application
      • 7.5.5.2.4 Market size and forecast, by End user
      • 7.5.5.3 South Africa
      • 7.5.5.3.1 Key market trends, growth factors and opportunities
      • 7.5.5.3.2 Market size and forecast, by Type
      • 7.5.5.3.3 Market size and forecast, by Application
      • 7.5.5.3.4 Market size and forecast, by End user
      • 7.5.5.4 Rest of LAMEA
      • 7.5.5.4.1 Key market trends, growth factors and opportunities
      • 7.5.5.4.2 Market size and forecast, by Type
      • 7.5.5.4.3 Market size and forecast, by Application
      • 7.5.5.4.4 Market size and forecast, by End user

CHAPTER 8: COMPANY LANDSCAPE

  • 8.1. Introduction
  • 8.2. Top winning strategies
  • 8.3. Product Mapping of Top 10 Player
  • 8.4. Competitive Dashboard
  • 8.5. Competitive Heatmap
  • 8.6. Key developments

CHAPTER 9: COMPANY PROFILES

  • 9.1 Ultravoice Limited
    • 9.1.1 Company overview
    • 9.1.2 Company snapshot
    • 9.1.3 Operating business segments
    • 9.1.4 Product portfolio
    • 9.1.5 Business performance
    • 9.1.6 Key strategic moves and developments
  • 9.2 Inhealth Technologies
    • 9.2.1 Company overview
    • 9.2.2 Company snapshot
    • 9.2.3 Operating business segments
    • 9.2.4 Product portfolio
    • 9.2.5 Business performance
    • 9.2.6 Key strategic moves and developments
  • 9.3 Griffin Labs
    • 9.3.1 Company overview
    • 9.3.2 Company snapshot
    • 9.3.3 Operating business segments
    • 9.3.4 Product portfolio
    • 9.3.5 Business performance
    • 9.3.6 Key strategic moves and developments
  • 9.4 Servona GmbH
    • 9.4.1 Company overview
    • 9.4.2 Company snapshot
    • 9.4.3 Operating business segments
    • 9.4.4 Product portfolio
    • 9.4.5 Business performance
    • 9.4.6 Key strategic moves and developments
  • 9.5 Labex Trade
    • 9.5.1 Company overview
    • 9.5.2 Company snapshot
    • 9.5.3 Operating business segments
    • 9.5.4 Product portfolio
    • 9.5.5 Business performance
    • 9.5.6 Key strategic moves and developments
  • 9.6 AMPLICORD DI GABRIELLA SALVATORE
    • 9.6.1 Company overview
    • 9.6.2 Company snapshot
    • 9.6.3 Operating business segments
    • 9.6.4 Product portfolio
    • 9.6.5 Business performance
    • 9.6.6 Key strategic moves and developments
  • 9.7 Romet Limted
    • 9.7.1 Company overview
    • 9.7.2 Company snapshot
    • 9.7.3 Operating business segments
    • 9.7.4 Product portfolio
    • 9.7.5 Business performance
    • 9.7.6 Key strategic moves and developments
  • 9.8 Nu-Vois, LLC
    • 9.8.1 Company overview
    • 9.8.2 Company snapshot
    • 9.8.3 Operating business segments
    • 9.8.4 Product portfolio
    • 9.8.5 Business performance
    • 9.8.6 Key strategic moves and developments
  • 9.9 Andreas Fahl Medizintechnik - Vertrieb GmbH
    • 9.9.1 Company overview
    • 9.9.2 Company snapshot
    • 9.9.3 Operating business segments
    • 9.9.4 Product portfolio
    • 9.9.5 Business performance
    • 9.9.6 Key strategic moves and developments
  • 9.10 Atos Medical AB
    • 9.10.1 Company overview
    • 9.10.2 Company snapshot
    • 9.10.3 Operating business segments
    • 9.10.4 Product portfolio
    • 9.10.5 Business performance
    • 9.10.6 Key strategic moves and developments

LIST OF TABLES

  • TABLE 1. GLOBAL ELECTROLARYNX MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 2. ELECTROLARYNX MARKET FOR BUILT-IN BATTERY, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 3. ELECTROLARYNX MARKET FOR BUILT-IN BATTERY, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 4. ELECTROLARYNX MARKET FOR EXTERNAL BATTERY, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 5. ELECTROLARYNX MARKET FOR EXTERNAL BATTERY, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 6. GLOBAL ELECTROLARYNX MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 7. ELECTROLARYNX MARKET FOR LARYNGEAL CANCER, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 8. ELECTROLARYNX MARKET FOR LARYNGEAL CANCER, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 9. ELECTROLARYNX MARKET FOR SPEECH REHABILITATION, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 10. ELECTROLARYNX MARKET FOR SPEECH REHABILITATION, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 11. GLOBAL ELECTROLARYNX MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 12. ELECTROLARYNX MARKET FOR HOSPITALS, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 13. ELECTROLARYNX MARKET FOR HOSPITALS, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 14. ELECTROLARYNX MARKET FOR AMBULATORY SURGICAL CENTERS, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 15. ELECTROLARYNX MARKET FOR AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 16. ELECTROLARYNX MARKET FOR OTHERS, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 17. ELECTROLARYNX MARKET FOR OTHERS, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 18. ELECTROLARYNX MARKET, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 19. NORTH AMERICA ELECTROLARYNX MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 20. NORTH AMERICA ELECTROLARYNX MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 21. NORTH AMERICA ELECTROLARYNX MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 22. NORTH AMERICA ELECTROLARYNX MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 23. U.S. ELECTROLARYNX MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 24. U.S. ELECTROLARYNX MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 25. U.S. ELECTROLARYNX MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 26. CANADA ELECTROLARYNX MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 27. CANADA ELECTROLARYNX MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 28. CANADA ELECTROLARYNX MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 29. MEXICO ELECTROLARYNX MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 30. MEXICO ELECTROLARYNX MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 31. MEXICO ELECTROLARYNX MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 32. EUROPE ELECTROLARYNX MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 33. EUROPE ELECTROLARYNX MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 34. EUROPE ELECTROLARYNX MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 35. EUROPE ELECTROLARYNX MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 36. GERMANY ELECTROLARYNX MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 37. GERMANY ELECTROLARYNX MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 38. GERMANY ELECTROLARYNX MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 39. FRANCE ELECTROLARYNX MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 40. FRANCE ELECTROLARYNX MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 41. FRANCE ELECTROLARYNX MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 42. UK ELECTROLARYNX MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 43. UK ELECTROLARYNX MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 44. UK ELECTROLARYNX MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 45. ITALY ELECTROLARYNX MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 46. ITALY ELECTROLARYNX MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 47. ITALY ELECTROLARYNX MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 48. SPAIN ELECTROLARYNX MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 49. SPAIN ELECTROLARYNX MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 50. SPAIN ELECTROLARYNX MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 51. REST OF EUROPE ELECTROLARYNX MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 52. REST OF EUROPE ELECTROLARYNX MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 53. REST OF EUROPE ELECTROLARYNX MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 54. ASIA-PACIFIC ELECTROLARYNX MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 55. ASIA-PACIFIC ELECTROLARYNX MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 56. ASIA-PACIFIC ELECTROLARYNX MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 57. ASIA-PACIFIC ELECTROLARYNX MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 58. JAPAN ELECTROLARYNX MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 59. JAPAN ELECTROLARYNX MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 60. JAPAN ELECTROLARYNX MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 61. CHINA ELECTROLARYNX MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 62. CHINA ELECTROLARYNX MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 63. CHINA ELECTROLARYNX MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 64. AUSTRALIA ELECTROLARYNX MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 65. AUSTRALIA ELECTROLARYNX MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 66. AUSTRALIA ELECTROLARYNX MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 67. INDIA ELECTROLARYNX MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 68. INDIA ELECTROLARYNX MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 69. INDIA ELECTROLARYNX MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 70. SOUTH KOREA ELECTROLARYNX MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 71. SOUTH KOREA ELECTROLARYNX MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 72. SOUTH KOREA ELECTROLARYNX MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 73. REST OF ASIA-PACIFIC ELECTROLARYNX MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 74. REST OF ASIA-PACIFIC ELECTROLARYNX MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 75. REST OF ASIA-PACIFIC ELECTROLARYNX MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 76. LAMEA ELECTROLARYNX MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 77. LAMEA ELECTROLARYNX MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 78. LAMEA ELECTROLARYNX MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 79. LAMEA ELECTROLARYNX MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 80. BRAZIL ELECTROLARYNX MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 81. BRAZIL ELECTROLARYNX MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 82. BRAZIL ELECTROLARYNX MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 83. SAUDI ARABIA ELECTROLARYNX MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 84. SAUDI ARABIA ELECTROLARYNX MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 85. SAUDI ARABIA ELECTROLARYNX MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 86. SOUTH AFRICA ELECTROLARYNX MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 87. SOUTH AFRICA ELECTROLARYNX MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 88. SOUTH AFRICA ELECTROLARYNX MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 89. REST OF LAMEA ELECTROLARYNX MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 90. REST OF LAMEA ELECTROLARYNX MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 91. REST OF LAMEA ELECTROLARYNX MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 92.ULTRAVOICE LIMITED: COMPANY SNAPSHOT
  • TABLE 93.ULTRAVOICE LIMITED: OPERATING SEGMENTS
  • TABLE 94.ULTRAVOICE LIMITED: PRODUCT PORTFOLIO
  • TABLE 95.ULTRAVOICE LIMITED: NET SALES
  • TABLE 96.ULTRAVOICE LIMITED: KEY STRATERGIES
  • TABLE 97.INHEALTH TECHNOLOGIES: COMPANY SNAPSHOT
  • TABLE 98.INHEALTH TECHNOLOGIES: OPERATING SEGMENTS
  • TABLE 99.INHEALTH TECHNOLOGIES: PRODUCT PORTFOLIO
  • TABLE 100.INHEALTH TECHNOLOGIES: NET SALES
  • TABLE 101.INHEALTH TECHNOLOGIES: KEY STRATERGIES
  • TABLE 102.GRIFFIN LABS: COMPANY SNAPSHOT
  • TABLE 103.GRIFFIN LABS: OPERATING SEGMENTS
  • TABLE 104.GRIFFIN LABS: PRODUCT PORTFOLIO
  • TABLE 105.GRIFFIN LABS: NET SALES
  • TABLE 106.GRIFFIN LABS: KEY STRATERGIES
  • TABLE 107.SERVONA GMBH: COMPANY SNAPSHOT
  • TABLE 108.SERVONA GMBH: OPERATING SEGMENTS
  • TABLE 109.SERVONA GMBH: PRODUCT PORTFOLIO
  • TABLE 110.SERVONA GMBH: NET SALES
  • TABLE 111.SERVONA GMBH: KEY STRATERGIES
  • TABLE 112.LABEX TRADE: COMPANY SNAPSHOT
  • TABLE 113.LABEX TRADE: OPERATING SEGMENTS
  • TABLE 114.LABEX TRADE: PRODUCT PORTFOLIO
  • TABLE 115.LABEX TRADE: NET SALES
  • TABLE 116.LABEX TRADE: KEY STRATERGIES
  • TABLE 117.AMPLICORD DI GABRIELLA SALVATORE: COMPANY SNAPSHOT
  • TABLE 118.AMPLICORD DI GABRIELLA SALVATORE: OPERATING SEGMENTS
  • TABLE 119.AMPLICORD DI GABRIELLA SALVATORE: PRODUCT PORTFOLIO
  • TABLE 120.AMPLICORD DI GABRIELLA SALVATORE: NET SALES
  • TABLE 121.AMPLICORD DI GABRIELLA SALVATORE: KEY STRATERGIES
  • TABLE 122.ROMET LIMTED: COMPANY SNAPSHOT
  • TABLE 123.ROMET LIMTED: OPERATING SEGMENTS
  • TABLE 124.ROMET LIMTED: PRODUCT PORTFOLIO
  • TABLE 125.ROMET LIMTED: NET SALES
  • TABLE 126.ROMET LIMTED: KEY STRATERGIES
  • TABLE 127.NU-VOIS, LLC: COMPANY SNAPSHOT
  • TABLE 128.NU-VOIS, LLC: OPERATING SEGMENTS
  • TABLE 129.NU-VOIS, LLC: PRODUCT PORTFOLIO
  • TABLE 130.NU-VOIS, LLC: NET SALES
  • TABLE 131.NU-VOIS, LLC: KEY STRATERGIES
  • TABLE 132.ANDREAS FAHL MEDIZINTECHNIK - VERTRIEB GMBH: COMPANY SNAPSHOT
  • TABLE 133.ANDREAS FAHL MEDIZINTECHNIK - VERTRIEB GMBH: OPERATING SEGMENTS
  • TABLE 134.ANDREAS FAHL MEDIZINTECHNIK - VERTRIEB GMBH: PRODUCT PORTFOLIO
  • TABLE 135.ANDREAS FAHL MEDIZINTECHNIK - VERTRIEB GMBH: NET SALES
  • TABLE 136.ANDREAS FAHL MEDIZINTECHNIK - VERTRIEB GMBH: KEY STRATERGIES
  • TABLE 137.ATOS MEDICAL AB: COMPANY SNAPSHOT
  • TABLE 138.ATOS MEDICAL AB: OPERATING SEGMENTS
  • TABLE 139.ATOS MEDICAL AB: PRODUCT PORTFOLIO
  • TABLE 140.ATOS MEDICAL AB: NET SALES
  • TABLE 141.ATOS MEDICAL AB: KEY STRATERGIES

LIST OF FIGURES

  • FIGURE 1.ELECTROLARYNX MARKET SEGMENTATION
  • FIGURE 2.ELECTROLARYNX MARKET,2021-2031
  • FIGURE 3.ELECTROLARYNX MARKET,2021-2031
  • FIGURE 4. TOP INVESTMENT POCKETS, BY REGION
  • FIGURE 5.PORTER FIVE-1
  • FIGURE 6.PORTER FIVE-2
  • FIGURE 7.PORTER FIVE-3
  • FIGURE 8.PORTER FIVE-4
  • FIGURE 9.PORTER FIVE-5
  • FIGURE 10.TOP PLAYER POSITIONING
  • FIGURE 11.ELECTROLARYNX MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
  • FIGURE 12.ELECTROLARYNX MARKET,BY TYPE,2021(%)
  • FIGURE 13.COMPARATIVE SHARE ANALYSIS OF BUILT-IN BATTERY ELECTROLARYNX MARKET,2021-2031(%)
  • FIGURE 14.COMPARATIVE SHARE ANALYSIS OF EXTERNAL BATTERY ELECTROLARYNX MARKET,2021-2031(%)
  • FIGURE 15.ELECTROLARYNX MARKET,BY APPLICATION,2021(%)
  • FIGURE 16.COMPARATIVE SHARE ANALYSIS OF LARYNGEAL CANCER ELECTROLARYNX MARKET,2021-2031(%)
  • FIGURE 17.COMPARATIVE SHARE ANALYSIS OF SPEECH REHABILITATION ELECTROLARYNX MARKET,2021-2031(%)
  • FIGURE 18.ELECTROLARYNX MARKET,BY END USER,2021(%)
  • FIGURE 19.COMPARATIVE SHARE ANALYSIS OF HOSPITALS ELECTROLARYNX MARKET,2021-2031(%)
  • FIGURE 20.COMPARATIVE SHARE ANALYSIS OF AMBULATORY SURGICAL CENTERS ELECTROLARYNX MARKET,2021-2031(%)
  • FIGURE 21.COMPARATIVE SHARE ANALYSIS OF OTHERS ELECTROLARYNX MARKET,2021-2031(%)
  • FIGURE 22.ELECTROLARYNX MARKET BY REGION,2021
  • FIGURE 23.U.S. ELECTROLARYNX MARKET,2021-2031($MILLION)
  • FIGURE 24.CANADA ELECTROLARYNX MARKET,2021-2031($MILLION)
  • FIGURE 25.MEXICO ELECTROLARYNX MARKET,2021-2031($MILLION)
  • FIGURE 26.GERMANY ELECTROLARYNX MARKET,2021-2031($MILLION)
  • FIGURE 27.FRANCE ELECTROLARYNX MARKET,2021-2031($MILLION)
  • FIGURE 28.UK ELECTROLARYNX MARKET,2021-2031($MILLION)
  • FIGURE 29.ITALY ELECTROLARYNX MARKET,2021-2031($MILLION)
  • FIGURE 30.SPAIN ELECTROLARYNX MARKET,2021-2031($MILLION)
  • FIGURE 31.REST OF EUROPE ELECTROLARYNX MARKET,2021-2031($MILLION)
  • FIGURE 32.JAPAN ELECTROLARYNX MARKET,2021-2031($MILLION)
  • FIGURE 33.CHINA ELECTROLARYNX MARKET,2021-2031($MILLION)
  • FIGURE 34.AUSTRALIA ELECTROLARYNX MARKET,2021-2031($MILLION)
  • FIGURE 35.INDIA ELECTROLARYNX MARKET,2021-2031($MILLION)
  • FIGURE 36.SOUTH KOREA ELECTROLARYNX MARKET,2021-2031($MILLION)
  • FIGURE 37.REST OF ASIA-PACIFIC ELECTROLARYNX MARKET,2021-2031($MILLION)
  • FIGURE 38.BRAZIL ELECTROLARYNX MARKET,2021-2031($MILLION)
  • FIGURE 39.SAUDI ARABIA ELECTROLARYNX MARKET,2021-2031($MILLION)
  • FIGURE 40.SOUTH AFRICA ELECTROLARYNX MARKET,2021-2031($MILLION)
  • FIGURE 41.REST OF LAMEA ELECTROLARYNX MARKET,2021-2031($MILLION)
  • FIGURE 42. TOP WINNING STRATEGIES, BY YEAR
  • FIGURE 43. TOP WINNING STRATEGIES, BY DEVELOPMENT
  • FIGURE 44. TOP WINNING STRATEGIES, BY COMPANY
  • FIGURE 45.PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 46.COMPETITIVE DASHBOARD
  • FIGURE 47.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS
  • FIGURE 48.ULTRAVOICE LIMITED.: NET SALES ($MILLION)
  • FIGURE 49.INHEALTH TECHNOLOGIES.: NET SALES ($MILLION)
  • FIGURE 50.GRIFFIN LABS.: NET SALES ($MILLION)
  • FIGURE 51.SERVONA GMBH.: NET SALES ($MILLION)
  • FIGURE 52.LABEX TRADE.: NET SALES ($MILLION)
  • FIGURE 53.AMPLICORD DI GABRIELLA SALVATORE.: NET SALES ($MILLION)
  • FIGURE 54.ROMET LIMTED.: NET SALES ($MILLION)
  • FIGURE 55.NU-VOIS, LLC.: NET SALES ($MILLION)
  • FIGURE 56.ANDREAS FAHL MEDIZINTECHNIK - VERTRIEB GMBH.: NET SALES ($MILLION)
  • FIGURE 57.ATOS MEDICAL AB.: NET SALES ($MILLION)